EBD Blog

Based on the work of a task force composed of highly qualified individuals, the Association for Behavior Analysis International (ABAI) has issued position statement about the use of restraint and seclusion in treatment. Members of the task force, which was appointed by the executive board, include Jon S. Bailey, Michael F. Dorsey, Louis P. Hagopian, Gregory P. Hanley, David B. Lennox, Mary M. Riordan, Scott Spreat, and Timothy R. Vollmer (chair).

The Association for Behavior Analysis International (ABAI) and its members strongly oppose the inappropriate and/or unnecessary use of seclusion, restraint, or other intrusive interventions. Although many persons with severe behavior problems can be effectively treated without the use of any restrictive interventions, restraint may be necessary on some rare occasions with meticulous clinical oversight and controls. In addition, a carefully planned and monitored use of timeout from reinforcement can be acceptable under restricted circumstances. Seclusion is sometimes necessary or needed, but behavior analysts would support only the most highly monitored and ethical practices associated with such use, to be detailed below.

In the “below,” the document goes on to present in detail the a set of guiding principles and specific recommendations about the use of seclusion and restraint. Read the statement, “ABAI Statement on Restraint and Seculsion” from the ABAI Website.

Those who subscribe to it know that the summer issue of Science in Autism Treatment, the newsletter for the Association for Science in Autism Treatment (ASAT), arrived today in their electronic mailboxes. For folks who are interested in Autism but who do not subscribe, here’s a catalog of content in this issue.
Continue reading ‘ASAT newsletter available’

The U.S. Food and Drug Administration (FDA) issued a warning letter to the producer of a product that is sometimes used by people hoping to eliminate heavy metals from children’s bodies (e.g., chelate mercury from children with autism). In a letter addressed to Boyd D. Haley of CTI Science Inc., Teresa C. Thompson of the Cincinnati District Office of the FDA cited a host of problems in the classification and marketing of the product, OSR#1. Among these problems are the following:
Continue reading ‘FDA warns seller of chelation product’

Thanks to Liz Ditz, I learned about this fun testimonial from Shannon Rosa:

My son Leo’s life was transformed when a five-dollar raffle ticket turned into a brand-new iPad. I’m not exaggerating. Before the iPad, Leo’s autism made him dependent on others for entertainment, play, learning, and communication. With the iPad, Leo electrifies the air around him with independence and daily new skills. People who know Leo are amazed when they see this new boy rocking that iPad. I’m impressed, too, especially when our aggressively food-obsessed boy chooses to play with his iPad rather than eat. I don’t usually dabble in miracle-speak, but I may erect a tiny altar to Steve Jobs in the corner of our living room.

Link to The iPad: a Near-Miracle for My Son With Autism

Over on Science Based Medicine, David Gorsky has an extended post explaining the finding reported in “Functional Impact of Global Rare Copy Number Variation in Autism Spectrum Disorders” by Dalila Pinto and colleagues (and there are ship load of colleagues) that appeared in Nature. Dr. Pinto and colleagues examined copy number variations (CNVs; deletions, insertions, duplications, and other differences in genetic structure that have been a hot topic in genetics since ~2007) that are associated with Autism. Dr. Gorsky’s summary is well worth the read, saving me the task of summarizing this important report.

In an editorial under the headline “Bad science gets its due,” the editors of the Boston (MA) Globe lament the consequences of Andrew Wakefield’s promotion of a connection between vaccines and Autism. At the end of the piece, the editorialist makes an important point:

But sadder still is the possibility that, in the minds of thousands of parents desperately clinging to hopes of finding a cure for autism, Wakefield’s legend might survive untarnished, possibly even exalted. In reality, his work on autism offers an unfortunate example of poor research trumping the scientific method.

Too bad the writer overlooked some of the other consequences. Here are a few nominees for a list repercussions:
Continue reading ‘Bad science?’

In “Handcuffing revives autism reform calls,” Natalie Craig reported about a story that, it seems to me, we’ve heard sometime before now.

POLICE handcuffed a 10-year-old autistic boy at a Geelong primary school after a breakdown in which he threw a compass that speared a classmate’s leg.

Link to the full version of Ms. Craig’s story.

Under the headline “Time to reexamine bipolar diagnosis in children,” Brendan Borrell reports on proposed changes in the American Psychiatric Association
s Diagnostic and Statistical Manual for the identification of bipolar disorder. In addition to presenting the basic information, Mr. Borrell has alternative views by Dr. Gabrielle Carlson and Dr. David Axelson.

Psychiatrists in favor of a new label, temper dysregulation disorder, cite a spike in bipolar diagnoses. But others worry it will add uncertainty to the treatment of an already confusing condition.

I wonder which side the psychiatrists who were concerned about the change from “manic depressive” to “bipolar” are on with this newest change. Will I have to change the category label in EBD Blog?

Link to Mr. Borrell’s story. Use the short link for this entry: http://wp.me/peQI7-iw

The publishers of Nature are promoting a new site, Scitable. The publishers bill Scitable as “a free science library and personal learning tool brought to you by Nature Publishing Group, the world’s leading publisher of science. Scitable currently concentrates on genetics, the study of evolution, variation, and the rich complexity of living organisms.” Autism is one of the topics featured at Scitable, so I’ll be reviewing what’s there and monitoring for updates about the scientific study of Autism at it’s “Spotlight on Autism.”

Over on Countering Age of Autism, Kim Wombles has an extended post about research on facilitated communication. She’s not just gathered together the evidence that is familiar to those who have followed the science, but also engaged in discussion in the comments section of the post. Take a look at Facilitated Communication: A Review of the Literature. While you’re there, check many of her other sensible and clear posts.

AST Online’s most recent newsletter (as of this date) provides lots of helpful information. Check it!

Source: Oznoff et al., 2010

In “A Prospective Study of the Emergence of Early Behavioral Signs of Autism,” Professor Sally Oznoff and colleagues found that infants who develop Autism behave differently than their typically developing peers even as early as one year of age. Writing in the Journal of the American Academy of Child & Adolescent Psychiatry, the researchers reported about a comparison of video tapes of children (n=50, half of whom had Autism) made at six-month intervals during infancy and early childhood.
Continue reading ‘Autism appears early’